Narrative review / 2012
Evidence for cinnamon's anti-diabetic effects is strong in animal models but conflicting in human clinical trials.
This review summarizes scientific literature on Cinnamomum aromaticum (Cassia) and Cinnamomum zeylanicum bark products. While in vitro and animal studies consistently demonstrated pronounced anti-diabetic and hypoglycemic activities alongside potential antimicrobial, antioxidant, and lipid-lowering properties, results from available human clinical trials remain conflicting. The authors emphasize the need for well-defined, adequately powered randomized controlled clinical trials before recommending cinnamon as an effective human treatment.
- Study type
- Narrative review
- Who was studied
- Human clinical trials, animal models, and in vitro studies
- What was measured
- Hypoglycaemic activity, lipid-lowering, blood pressure, and other bioactivities
THE PAPER
Bioactivity of cinnamon with special emphasis on diabetes mellitus: a review.
Bandara T, Uluwaduge I, Jansz ER. Int J Food Sci Nutr, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.